Precision Therapeutics gets $33M to support ChemoFx

Pittsburgh-based Precision Therapeutics has landed a $33 million venture capital round, with Bain Capital leading the Series D funding round. "That's twice what we shot for," said CEO Sean McDonald, who, according to the Pittsburgh Business Times, originally hoped to raise $15 million. "We grew quite a bit last year, and, consequently, we had a lot of interest from large VC firms." Additional investors included Adams Capital Management, Quaker BioVentures, and Birchmere...